Total Payments
$13,657
2024 Payments
$1,721
Companies
25
Transactions
786
Medicare Patients
9,856
Medicare Billing
$719,361
Payment Breakdown by Category
Food & Beverage$13,462 (98.6%)
Education$194.88 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,462 | 783 | 98.6% |
| Education | $194.88 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,764 | 200 | $0 (2024) |
| Janssen Biotech, Inc. | $1,480 | 104 | $0 (2024) |
| Amgen Inc. | $1,445 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,179 | 73 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,110 | 63 | $0 (2024) |
| GENZYME CORPORATION | $888.85 | 41 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $649.57 | 37 | $0 (2024) |
| PFIZER INC. | $505.56 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $503.28 | 26 | $0 (2024) |
| LEO Pharma Inc. | $363.83 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,721 | 89 | ABBVIE INC. ($560.78) |
| 2023 | $2,582 | 127 | ABBVIE INC. ($596.17) |
| 2022 | $2,361 | 147 | ABBVIE INC. ($673.90) |
| 2021 | $1,330 | 73 | AbbVie Inc. ($514.18) |
| 2020 | $1,017 | 59 | AbbVie Inc. ($290.79) |
| 2019 | $1,863 | 104 | AbbVie, Inc. ($514.12) |
| 2018 | $1,493 | 101 | AbbVie, Inc. ($307.32) |
| 2017 | $1,289 | 86 | AbbVie, Inc. ($306.38) |
All Payment Transactions
786 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.58 | General |
| Category: Immunology | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,388 | 4,432 | $681,219 | $182,670 |
| 2022 | 26 | 2,446 | 4,321 | $672,632 | $181,338 |
| 2021 | 25 | 2,641 | 4,579 | $734,900 | $205,617 |
| 2020 | 25 | 2,381 | 4,020 | $598,555 | $149,735 |
Total Patients
9,856
Total Services
17,352
Medicare Billing
$719,361
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 618 | 849 | $121,407 | $50,622 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 270 | $57,240 | $22,115 | 38.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 270 | 303 | $83,325 | $19,618 | 23.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 395 | 523 | $105,646 | $17,240 | 16.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 58 | 91 | $39,949 | $10,387 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 146 | 146 | $33,560 | $9,997 | 29.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 55 | 77 | $28,875 | $8,723 | 30.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 45 | 55 | $29,150 | $8,128 | 27.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 282 | 1,688 | $55,704 | $7,584 | 13.6% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 29 | 38 | $17,822 | $4,656 | 26.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 35 | 47 | $16,967 | $3,732 | 22.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 26 | 29 | $19,256 | $3,370 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 54 | 58 | $14,268 | $3,152 | 22.1% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 21 | 32 | $13,152 | $3,119 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,322 | $2,934 | 25.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 22 | 24 | $5,616 | $1,726 | 30.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 18 | $5,562 | $1,413 | 25.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 18 | $5,886 | $1,367 | 23.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 18 | $5,148 | $1,236 | 24.0% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $2,892 | $863.96 | 29.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 14 | $1,960 | $444.15 | 22.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 22 | $1,100 | $194.68 | 17.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 66 | $5,412 | $51.12 | 0.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 591 | 763 | $109,109 | $44,806 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 278 | 371 | $78,652 | $30,415 | 38.7% |
About Dr. Gerald Elliott, M.D
Dr. Gerald Elliott, M.D is a Dermatology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225063175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Elliott, M.D has received a total of $13,657 in payments from pharmaceutical and medical device companies, with $1,721 received in 2024. These payments were reported across 786 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($13,462).
As a Medicare-enrolled provider, Elliott has provided services to 9,856 Medicare beneficiaries, totaling 17,352 services with total Medicare billing of $719,361. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Pediatric Dermatology, Procedural Dermatology
- Location Lexington, KY
- Active Since 07/11/2006
- Last Updated 11/02/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225063175
Products in Payments
- SKYRIZI (Biological) $1,668
- TALTZ (Drug) $1,179
- Humira (Biological) $1,076
- TREMFYA (Drug) $1,057
- COSENTYX (Biological) $882.16
- Otezla (Drug) $860.64
- DUPIXENT (Biological) $855.02
- RINVOQ (Biological) $599.33
- Enbrel (Biological) $584.84
- ILUMYA (Biological) $509.67
- Sotyktu (Drug) $478.44
- EUCRISA (Drug) $471.39
- HUMIRA (Biological) $340.80
- ADBRY (Biological) $309.25
- Tremfya (Drug) $276.14
- OPZELURA (Drug) $179.04
- STELARA (Biological) $157.35
- DUPIXENT (Drug) $143.30
- COSENTYX (Drug) $141.40
- Cimzia (Drug) $140.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Lexington
Dr. Dana Black, M.d, M.D
Dermatology — Payments: $16,936
Dermatology $16,936
Dr. Jonathan Keeling, D.o, D.O
Dermatology — Payments: $13,957
Dermatology $13,957
Carol Thompson, Md, MD
Dermatology — Payments: $9,859
Dermatology $9,859
Dr. Erika Music, Md, MD
Dermatology — Payments: $8,825
Dermatology $8,825
Tessa Mullins, D.o, D.O
Dermatology — Payments: $7,458
Dermatology $7,458
Dr. James Lagrew, Md, MD
Dermatology — Payments: $6,601
Dermatology $6,601